// App-Quantinova.ai

P224 : Responder definitions for the ulcerative colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) tool using patients with ulcerative colitis treated with etrolizumab

Researchers

Presenter

  • P Higgins

Principal Investigators

  • A Matsui

  • K DeBusk

  • J Pulley

  • A Scalori

  • Y S Oh

  • U Arulmani

Medical Centers

  • University of Michigan, Ann Arbor, MI

  • Genentech, Inc., South San Francisico, CA

  • Roche, Burgess Hill, UK

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Etrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02100696

  • NCT02165215

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved